PATTERSON COMPANIES
Acquired by
PATIENT SQUARE CAPITAL
PATTERSON COMPANIES acquired by PATIENT SQUARE CAPITAL
Target
PATTERSON COMPANIES
Acquirer
PATIENT SQUARE CAPITAL
Context
Patient Square Capital completed the acquisition of 100% of Patterson Companies, taking the business private and delisting it from the NASDAQ Global Select Market. Patterson will maintain its headquarters in St. Paul, Minnesota. The transaction positions Patterson to accelerate its growth strategy and strengthen its offering to dental and animal health customers under Patient Square's healthcare-focused ownership and operational support.
PATTERSON COMPANIES, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN discount to the average currently observed in the Healthcare & Pharma sector (13.3x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Patterson Companies is a leading US-based distributor of products and services to two distinct end markets: (1) dental, providing dental practitioners and laboratories across North America and the UK with consumables, equipment, technology solutions, and value-added services; and (2) animal health, supplying veterinary practices and production animal operations through its Animal Health International subsidiary. The company operates a comprehensive portfolio combining product distribution with proprietary software, digital solutions, and practice management services, supported by an extensive logistics and supply chain network across North America and the UK.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (USD)
Other operations with PATTERSON COMPANIES
REFERENCES
Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Acquirer: patient square capital